Molly A. Hughes, Drusilla L. Burns, Stephen J. Juris, Wei-Jen Tang, Kristin H. Clement, Linda J. Eaton, Cassandra D. Kelly-Cirino, Marian L. McKee, Bradford S. Powell, Brian L. Bishop, Thomas L. Rudge, Nancy Shine, Anita Verma, Melissa Swope Willis, and Stephen A. Morse. (2009). The case for developing consensus standards for research in microbial pathogenesis: Bacillus anthracis toxins as an example. Infection and Immunity. In press.
Daniel Basilio, Stephen J. Juris, R. John Collier, and Alan Finkelstein. (2009). Evidence for a proton-protein symport mechanism in the anthrax toxin channel. Journal of General Physiology. 133: 307-314.
D. Shyamali Wimalasena, John C. Cramer, Blythe E. Janowiak, Stephen J. Juris, Roman A. Melnyk, D. Eric Anderson, Kenneth L. Kirk, R. John Collier, and James G. Bann. (2007). Effect of 2-fluorohistidine labeling of the anthrax protective antigen on stability, pore formation and translocation. Biochemistry. 46: 14928-14936.
Stephen J. Juris, Roman A. Melnyk, Robert E. Bolcome III, Joanne Chan, and R. John Collier. (2007). Crosslinked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin. Infection and Immunity. 75: 5052-5058.
Stephen J. Juris, Kavita Shah, Kevan Shokat, Jack E. Dixon, and Panayiotis O. Vacratsis. (2006). Identification of otubain 1 as a novel substrate for the Yersinia protein kinase using chemical genetics and mass spectrometry. FEBS Letters. 580: 179-183.
Bryan A. Krantz, Roman A. Melnyk, Sen Zhang, Stephen J. Juris, D. Borden Lacy, Zhengyan Wu, Alan Finkelstein, and R. John Collier. (2005). A phenylalanine clamp catalyzes protein translocation through the anthrax toxin pore. Science. 309: 777-781.
Darran J. Wigelsworth, Bryan A. Krantz, Kenneth A. Christensen, D. Borden Lacy, Stephen J. Juris, and R. John Collier. (2004). Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen. Journal of Biological Chemistry. 279: 23349-23356.
Stephen J. Juris, Feng Shao, and Jack E. Dixon. (2002). Yersinia effectors target mammalian signaling pathways. Cellular Microbiology. 4: 201-211.
Stephen J. Juris, Amy E. Rudolph, Don Huddler, Kim Orth, and Jack E. Dixon. (2000). A distinctive role for the Yersinia protein kinase: actin binding. kinase activation, and cytoskeleton disruption. Proceedings of the National Academy of Sciences U.S.A. 97: 9431-9436.